{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:55:07Z","timestamp":1753437307148},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.mehy.2009.10.034","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T16:18:00Z","timestamp":1258733880000},"page":"705-706","source":"Crossref","is-referenced-by-count":10,"title":["ACTH receptor blockade: A novel approach to treat congenital adrenal hyperplasia, or Cushing\u2019s disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Ron S.","family":"Newfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2009.10.034_bib1","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1073\/pnas.96.22.12790","article-title":"Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess","volume":"96","author":"New","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2009.10.034_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2009.10.034_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.7326\/0003-4819-136-4-200202190-00012","article-title":"NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"136","author":"Merke","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2009.10.034_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2265.2006.02740.x","article-title":"Congenital adrenal hyperplasia and P450 oxidoreductase deficiency","volume":"66","author":"Krone","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.mehy.2009.10.034_bib5","unstructured":"New MI, Gertner JM, Speiser PW, Del Balzo P. Growth and final height in classical and non-classical 21-hydroxylase deficiency. J Endocrinol Invest 1989;12 (8 Suppl. 3):91\u20135."},{"key":"10.1016\/j.mehy.2009.10.034_bib6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.10.034_bib7","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jc.85.3.1114","article-title":"Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia","volume":"85","author":"Merke","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.10.034_bib8","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/092986708786242921","article-title":"Steroid biosynthesis inhibitors in the therapy of hypercortisolism: theory and practice","volume":"15","author":"Igaz","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mehy.2009.10.034_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/JPEM.2001.14.3.229","article-title":"Graves\u2019 disease in childhood","volume":"14","author":"Kraiem","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.10.034_bib10","first-page":"183","article-title":"Infliximab in the treatment of rheumatoid arthritis","volume":"3","author":"Perdriger","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.mehy.2009.10.034_bib11","doi-asserted-by":"crossref","unstructured":"Chung TT, Chan LF, Metherell LA, Clark AJ. Phenotypic characteristics of Familial Glucocorticoid Deficiency type 1 and 2. Clin Endocrinol (Oxf) 2009;Jun 24. [Epub ahead of print].","DOI":"10.1111\/j.1365-2265.2009.03663.x"},{"key":"10.1016\/j.mehy.2009.10.034_bib12","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.peptides.2004.11.024","article-title":"A review of melanocortin receptor small molecule ligands","volume":"26","author":"Todorovic","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.mehy.2009.10.034_bib13","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jc.2008-0048","article-title":"A novel adrenocorticotropin receptor mutation alters its structure and function, causing familial glucocorticoid deficiency","volume":"93","author":"Artigas","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.10.034_bib14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/nbt1208-1336","article-title":"Automated de novo protein sequencing of monoclonal antibodies","volume":"26","author":"Bandeira","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mehy.2009.10.034_bib15","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1210\/jc.2003-032170","article-title":"Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm","volume":"89","author":"Ayala","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2009.10.034_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0022-3956(03)00070-0","article-title":"Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects","volume":"37","author":"K\u00fcnzel","year":"2003","journal-title":"J Psychiatr Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709007130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709007130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T23:59:14Z","timestamp":1558655954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709007130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0306987709007130"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.10.034","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}